Vericel (VCEL) Invested Capital (2010 - 2018)
Vericel (VCEL) posted Invested Capital of $4.1 million for Q3 2018, up 43.86% sequentially from $2.8 million in Q2 2018, and up 60.23% YoY from $2.6 million in Q3 2017.
Analysis
Vericel (VCEL) Invested Capital (2010 - 2018) Analysis & Trends
Vericel has reported Invested Capital for 8 years, with the latest figure at $4.1 million in Q3 2018.
- Quarterly Invested Capital rose 60.23% year-over-year to $4.1 million in Q3 2018, while the trailing twelve-month figure through Jun 2019 was $4.1 million (down 44.27% YoY) and the FY2017 annual result came in at $350000.0, down 55.07% from the prior year.
- Invested Capital advanced to $4.1 million in Q3 2018 per VCEL's latest filing, from $2.8 million in the prior quarter.
- Over five years, Invested Capital peaked at $5.6 million in Q3 2016 and troughed at $2000.0 in Q1 2014.
- A 4-year average of $2.0 million and a median of $1.6 million in 2014 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 15900.0% in 2014, down 92.59% in 2014.
- Over 4 years, Invested Capital stood at $348000.0 in 2014, then jumped by 123.85% to $779000.0 in 2016, then slumped by 55.07% to $350000.0 in 2017, then surged by 1070.57% to $4.1 million in 2018.
- According to Business Quant data, Invested Capital over the past three periods registered $4.1 million, $2.8 million, and $1.6 million for Q3 2018, Q2 2018, and Q1 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 102.23 Mn |
| Sep 30, 2018 | 111.76 Mn |
| Jun 30, 2018 | 109.41 Mn |
| Mar 31, 2018 | 40.10 Mn |
| Dec 31, 2017 | 40.79 Mn |
| Sep 30, 2017 | 27.96 Mn |
| Jun 30, 2017 | 24.33 Mn |
| Mar 31, 2017 | 26.28 Mn |
| Dec 31, 2016 | 26.28 Mn |
| Sep 30, 2016 | 17.66 Mn |
| Jun 30, 2016 | 17.16 Mn |
| Mar 31, 2016 | 19.29 Mn |
| Dec 31, 2015 | 22.96 Mn |
| Sep 30, 2015 | 26.49 Mn |
| Jun 30, 2015 | 30.34 Mn |
| Mar 31, 2015 | 31.80 Mn |
| Dec 31, 2014 | 36.10 Mn |
| Sep 30, 2014 | 39.50 Mn |
| Jun 30, 2014 | 7.79 Mn |
| Mar 31, 2014 | 3.77 Mn |